Synageva BioPharma Corp. , a biopharmaceutical company developing therapeutic products for rare disorders, today reported 2013 full year financial results and provided 2014 goals, other key objectives, and financial guidance.
http://ift.tt/1eYcv3g
http://ift.tt/1eYcv3g
No comments:
Post a Comment